These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35967487)

  • 1. Exploring the Effectiveness of Sustainability Measurement: Which ESG Metrics Will Survive COVID-19?
    Atkins J; Doni F; Gasperini A; Artuso S; La Torre I; Sorrentino L
    J Bus Ethics; 2022 Aug; ():1-18. PubMed ID: 35967487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Which institutional investors can improve the level of corporate ESG information disclosure?
    Wang J; Ke Y; Zhang H; Cheng Y
    PLoS One; 2023; 18(11):e0290008. PubMed ID: 37976317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How does ESG performance affect stock returns? Empirical evidence from listed companies in China.
    Yin XN; Li JP; Su CW
    Heliyon; 2023 May; 9(5):e16320. PubMed ID: 37305472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Environmental-, social-, and governance-related factors for business investment and sustainability: a scientometric review of global trends.
    Ahmad H; Yaqub M; Lee SH
    Environ Dev Sustain; 2023 Jan; ():1-23. PubMed ID: 36714213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of ESG Information Into Individual Investors' Corporate Investment Decisions: Utilizing the UTAUT Framework.
    Park SR; Oh KS
    Front Psychol; 2022; 13():899480. PubMed ID: 35548525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Government Environmental Regulation and Corporate ESG Performance: Evidence from Natural Resource Accountability Audits in China.
    Yan Y; Cheng Q; Huang M; Lin Q; Lin W
    Int J Environ Res Public Health; 2022 Dec; 20(1):. PubMed ID: 36612766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ESG performance in the time of COVID-19 pandemic: cross-country evidence.
    Al Amosh H; Khatib SFA
    Environ Sci Pollut Res Int; 2023 Mar; 30(14):39978-39993. PubMed ID: 36600157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of ESG performance during times of COVID-19 pandemic.
    Gao M; Geng X
    Sci Rep; 2024 Jan; 14(1):2553. PubMed ID: 38297089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating nutrition and obesity prevention considerations into institutional investment decisions regarding food companies: Australian investment sector perspectives.
    Robinson E; Parker C; Carey R; Foerster A; Blake MR; Sacks G
    Global Health; 2022 Nov; 18(1):93. PubMed ID: 36348484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Environmental, social, and governance (ESG) performance and financial outcomes: Analyzing the impact of ESG on financial performance.
    Chen S; Song Y; Gao P
    J Environ Manage; 2023 Nov; 345():118829. PubMed ID: 37688968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The independent and moderating role of choice of non-financial reporting format on forecast accuracy and ESG disclosure.
    Rossi P; Candio P
    J Environ Manage; 2023 Nov; 345():118891. PubMed ID: 37659364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corporate Social Responsibility Disclosure: Responding to Investors' Criticism on Social Media.
    Zhang Y; Yang F
    Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34299847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustainability and Financial Accounting: a Critical Review on the ESG Dynamics.
    Tettamanzi P; Venturini G; Murgolo M
    Environ Sci Pollut Res Int; 2022 Mar; 29(11):16758-16761. PubMed ID: 35025042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Landscape analysis of environmental, social and governance (ESG) investing metrics for consumer nutrition and health in the food and beverage sector.
    O'Hearn M; Reedy J; Robinson E; Economos C; Wong JB; Sacks G; Mozaffarian D
    BMJ Nutr Prev Health; 2023 Dec; 6(2):139-152. PubMed ID: 38264364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Environmental commitments and Innovation in China's corporate landscape: An analysis of ESG governance strategies.
    Kenneth David L; Wang J; Angel V; Luo M
    J Environ Manage; 2024 Jan; 349():119529. PubMed ID: 37951107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of ESG performance on the stock market during the COVID-19 Pandemic - Evidence from Japan.
    Liu L; Nemoto N; Lu C
    Econ Anal Policy; 2023 Jun; ():. PubMed ID: 38620119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of ESG performance during times of financial crisis: Evidence from COVID-19 in China.
    Broadstock DC; Chan K; Cheng LTW; Wang X
    Financ Res Lett; 2021 Jan; 38():101716. PubMed ID: 32837385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ESG did not immunize stocks during the COVID-19 crisis, but investments in intangible assets did.
    Demers E; Hendrikse J; Joos P; Lev B
    J Bus Finance Account; 2021; 48(3-4):433-462. PubMed ID: 34230747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How reactive is investment in US green bonds and ESG-eligible stocks in times of crisis? Exploring the COVID-19 crisis.
    Perote J; Vicente-Lorente JD; Zuñiga-Vicente JA
    Financ Res Lett; 2023 May; 53():103638. PubMed ID: 36643777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corporate sustainability performance, stock returns, and ESG indicators: fresh insights from EU member states.
    Ye C; Song X; Liang Y
    Environ Sci Pollut Res Int; 2022 Dec; 29(58):87680-87691. PubMed ID: 35819677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.